Document is current
Any future updates will be listed below
-
Authors
Krämer, Stefan https://orcid.org/0009-0004-9485-0969
Vogt, Kristian https://orcid.org/0009-0001-0137-4464
Schreibing, Theresa Maria https://orcid.org/0000-0003-0593-5123
Busch, Martin https://orcid.org/0000-0002-7889-6156
Schmitt, Tobias
Bergner, Raoul https://orcid.org/0000-0002-7965-1273
Mosberger, Sebastian https://orcid.org/0009-0001-1152-9925
Neumann, Thomas https://orcid.org/0000-0003-3755-9038
Rauen, Thomas https://orcid.org/0000-0002-6544-8901
-
Funding
Funding for this research was provided by:
Vifor Pharma (IIS-NA2021-0615)
Universitätsklinikum RWTH Aachen
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 16 November 2024
First Online: 24 December 2024
Declarations
:
: S. Krämer, K. Vogt, T. Schreibing, T. Schmitt, S. Mosberger: no disclosures.T. Rauen, M. Busch, R. Bergner, T. Neumann: received consultancy honoraria from Vifor Pharma.
: This retrospective analysis was approved by the involved local ethic committees (Aachen: EK 164/19, St. Gallen: 2020-01350, Jena: 2020-1837-Daten, Ludwigshafen: 2020-14843-Retrospective).
